Financial statements Lux Med Onkologia
Cash inflows of LUX MED ONKOLOGIA
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Net cash from operating expenses | 8 961,00 | 269 686,22 | 8 753 478,43 | 20 789 568,39 | 30 378 078,95 | 27 162 798,01 |
Net cash flow from investing activities | -1 674,00 | -3 072 931,36 | -4 324 136,05 | -6 495 126,82 | -11 397 378,41 | -12 958 459,03 |
Net cash flow from financial activities | -608,00 | -7 285 501,54 | -2 591 040,62 | -7 042 101,40 | -13 404 005,25 | -12 137 832,75 |
Total net cash flow | 6 679,00 | -10 088 746,68 | 1 838 301,76 | 7 252 340,17 | 5 576 695,29 | 2 066 506,23 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.